Results for tag: "Diabetes Insipidus Drug"

Diabetes Insipidus (DI) is a rare endocrine disorder characterized by excessive thirst and the excretion of large amounts of dilute urine. Treatment of DI is focused on replacing the deficient hormone, vasopressin, which is responsible for regulating the body's water balance. Endocrine and Metabolic Disorders Drugs are used to treat a variety of endocrine and metabolic disorders, including DI. The Diabetes Insipidus Drug market is composed of a variety of drugs used to treat DI, including desmopressin, a synthetic form of vasopressin, and other drugs such as thiazide diuretics and non-steroidal anti-inflammatory drugs. These drugs are used to reduce the amount of urine produced and to increase the body's ability to retain water. The market for Diabetes Insipidus Drugs is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Novartis, Pfizer, Merck, Sanofi, and Eli Lilly. Show Less Read more